Direct Treatment Costs of Neovascular Age-related Macular Degeneration and Comparison of Gained and/or Preserved Vision with Expenditure

Direct Treatment Costs of Neovascular Age-related Macular Degeneration and Comparison of Gained and/or Preserved Vision with Expenditure

Objectives: The aim was to quantify the direct medical cost of neovascular age-related macular degeneration (AMD) versus gained or preserved vision. Materials and Methods: Data of patients treated for neovascular AMD between January 2009 to January 2014 were reviewed. Patients with complete follow-...

Full description

Bibliographic Details
Main Authors: Şeyda Yıldırım, Cezmi Akkın, Zafer Öztaş, Serhad Nalçacı, Filiz Afrashi, Jale Menteş
Format: Article
Language:English
Published: Galenos Yayinevi 2018-02-01
Series:Türk Oftalmoloji Dergisi
Subjects:
Age-related macular degeneration
direct medical cost
ranibizumab
Online Access:http://www.oftalmoloji.org/archives/archive-detail/article-preview/direct-treatment-costs-of-neovascular-age-related-/16749

Similar Items

Similar Items